Asthma & COPD Drugs Market - Forecast, 2022-2027
Asthma & COPD Drugs Market size is estimated to reach $42.1 billion by 2027 , growing at a CAGR of 4.7% during the forecast period 2022-2027. Asthma & COPD Drugs have the principal goal to reverse bronchoconstriction which is hindering the airway to enhance air flow in and out of the lungs. Bronchodilators are principal in the treatment of airways ailments. They are the backbone of the present handling of chronic obstructive pulmonary disease (COPD) and are crucial in the symptomatic handling of asthma, though controversies around the application of these medications prevail. Anticholinergics have vital applications as bronchodilators for the treatment of obstructive airway ailments like both asthma and, more specifically, chronic obstructive pulmonary disease (COPD). Inhaled corticosteroids (ICS), also termed inhaled steroids, are the most powerful anti-inflammatory controller medicines accessible presently for asthma regulation an...